AstraZeneca: UK-based pharmaceutical company with a strong oncology pipeline.
Price
168.72
24H
—
Volume 24h
$82.41K
OI (USD)
$2.08M
Market Cap
$261.38B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | AZNSTOCK_USDT | 168.72 | 168.74 | -1.2 bps | -13.25% -0.0121% / 8h · -- | $82.41K | 100.0% | $2.08M | 86d |
News
15AZN▼AstraZeneca breast-cancer drug fails late-stage trial goal
8dAZN▲AstraZeneca tozorakimab cuts COPD exacerbations by 29% in TITANIA
×214dAZN▲AZN listed on BingX
14dAZN▲FDA grants accelerated approval to AstraZeneca's Etcamah for breast cancer
×218dAZN▼AstraZeneca terminates volrustomig lung cancer trial, efficacy falls short of Keytruda.
×22026-08-17